FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Prete, G.
Right arrow Articles by Romagnani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Prete, G.
Right arrow Articles by Romagnani, S.

The FASEB Journal, Vol 9, 81-86, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Preferential expression of CD30 by human CD4+ T cells producing Th2- type cytokines

G Del Prete, M De Carli, F Almerigogna, CK Daniel, MM D'Elios, G Zancuoghi, F Vinante, G Pizzolo and S Romagnani
Division of Clinical Immunology and Allergology, University of Florence, Italy.

A large panel of human CD4+ T helper (Th) cell clones with established Th1, Th2, or Th0 profiles of cytokine secretion were examined for the expression of CD30, a member of the tumor necrosis factor receptor superfamily. Th1 clones expressed poor or no CD30 mRNA, and showed low or undetectable expression of both membrane and soluble CD30 (sCD30) protein, whereas Th2 clones showed both CD30 mRNA and membrane CD30 and released substantial amounts of sCD30. Th0 clones exhibited an intermediate pattern of CD30 expression and release. When T cells from the same donor were stimulated with three different antigens (purified protein derivative, PPD; Toxocara canis excretory/secretory antigen, TES; Lolium perenne group I, Lol p I), production of high concentrations of IFN-gamma, but not expression of CD30 or production of IL-4 and IL-5, were observed at any time after stimulation with PPD. In contrast, both CD30 expression and production of IL-4 and IL-5, but not of IFN-gamma, were concomitantly detectable in TES- and Lol p I- reactive T cells, suggesting a temporal relationship between CD30 expression and beginning of Th2-type cytokine production. Finally, CD4+CD30+ T cells specific for Lol p I and inducible to production of Th2-type cytokines were sorted out from the circulation of grass- sensitive patients in concomitance with the onset of allergic symptoms during the seasonal exposure to grass pollen. Thus, CD30 expression appears to be associated with the differentiation/activation pathway of human T cells producing Th2-type cytokines.


This article has been cited by other articles:


Home page
 Int ImmunolHome page
S.-Y. Nam, Y.-H. Kim, J.-S. Do, Y.-H. Choi, H.-J. Seo, H.-K. Yi, P.-H. Hwang, C.-H. Song, H.-K. Lee, J.-S. Kim, et al.
CD30 supports lung inflammation
Int. Immunol., February 1, 2008; 20(2): 177 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Nishimura, T. Yajima, H. Muta, E. R. Podack, K. Tani, and Y. Yoshikai
A Novel Role of CD30/CD30 Ligand Signaling in the Generation of Long-Lived Memory CD8+ T Cells
J. Immunol., October 1, 2005; 175(7): 4627 - 4634.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M Ostensen, F Forger, J L Nelson, A Schuhmacher, G Hebisch, and P M Villiger
Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum
Ann Rheum Dis, June 1, 2005; 64(6): 839 - 844.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. M. C. Gaspal, M.-Y. Kim, F. M. McConnell, C. Raykundalia, V. Bekiaris, and P. J. L. Lane
Mice Deficient in OX40 and CD30 Signals Lack Memory Antibody Responses because of Deficient CD4 T Cell Memory
J. Immunol., April 1, 2005; 174(7): 3891 - 3896.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Florido, M. Borges, H. Yagita, and R. Appelberg
Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium
J. Leukoc. Biol., November 1, 2004; 76(5): 1039 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. P. Singh, S. Singh, P. Ravichandran, D. D. Taub, and J. W. Lillard Jr.
Viral Macrophage-Inflammatory Protein-II: A Viral Chemokine That Differentially Affects Adaptive Mucosal Immunity Compared with Its Mammalian Counterparts
J. Immunol., November 1, 2004; 173(9): 5509 - 5516.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. R. Blazar, R. B. Levy, T. W. Mak, A. Panoskaltsis-Mortari, H. Muta, M. Jones, M. Roskos, J. S. Serody, H. Yagita, E. R. Podack, et al.
CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease
J. Immunol., September 1, 2004; 173(5): 2933 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. von Tresckow, K.-J. Kallen, E. P. von Strandmann, P. Borchmann, H. Lange, A. Engert, and H. P. Hansen
Depletion of Cellular Cholesterol and Lipid Rafts Increases Shedding of CD30
J. Immunol., April 1, 2004; 172(7): 4324 - 4331.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
T. Nijsten, C. Curiel-Lewandrowski, and M. E. Kadin
Lymphomatoid Papulosis in Children: A Retrospective Cohort Study of 35 Cases
Arch Dermatol, March 1, 2004; 140(3): 306 - 312.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. A. Phillips, J. Ni, and J. S. Hunt
Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas
J. Leukoc. Biol., July 1, 2003; 74(1): 81 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Sasaki, T. Tsuji, T. Jinushi, J. Matsuzaki, T. Sato, K. Chamoto, Y. Togashi, T. Koda, and T. Nishimura
Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets
Int. Immunol., June 1, 2003; 15(6): 701 - 710.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Gerli, C. Lunardi, and C. Pitzalis
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis
Rheumatology, December 1, 2002; 41(12): 1341 - 1345.
[Full Text] [PDF]

Home page
 CVIHome page
F. Monsalve-de Castillo, T. A. Romero, J. Estevez, L. L. Costa, R. Atencio, L. Porto, and D. Callejas
Concentrations of Cytokines, Soluble Interleukin-2 Receptor, and Soluble CD30 in Sera of Patients with Hepatitis B Virus Infection during Acute and Convalescent Phases
Clin. Vaccine Immunol., November 1, 2002; 9(6): 1372 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Saraiva, P. Smith, P. G. Fallon, and A. Alcami
Inhibition of Type 1 Cytokine-mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus
J. Exp. Med., September 16, 2002; 196(6): 829 - 839.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Susal, S. Pelzl, B. Dohler, and G. Opelz
Identification of Highly Responsive Kidney Transplant Recipients Using Pretransplant Soluble CD30
J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1650 - 1656.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
C. Lienhardt, S. Bennett, G. Del Prete, O. Bah-Sow, M. Newport, P. Gustafson, K. Manneh, V. Gomes, A. Hill, and K. McAdam
Investigation of Environmental and Host-related Risk Factors for Tuberculosis in Africa. I. Methodological Aspects of a Combined Design
Am. J. Epidemiol., June 1, 2002; 155(11): 1066 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Yamada, A. D. Salama, and M. H. Sayegh
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575.
[Full Text] [PDF]

Home page
 BloodHome page
F. Vinante, A. Rigo, M. T. Scupoli, and G. Pizzolo
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540
Blood, January 1, 2002; 99(1): 52 - 60.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. L. Chan, N. Pejnovic, C. A. Lee, and N. A. Al-Ali
Human IL-18 Receptor and ST2L Are Stable and Selective Markers for the Respective Type 1 and Type 2 Circulating Lymphocytes
J. Immunol., August 1, 2001; 167(3): 1238 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Lillard Jr., P. N. Boyaka, D. D. Taub, and J. R. McGhee
RANTES Potentiates Antigen-Specific Mucosal Immune Responses
J. Immunol., January 1, 2001; 166(1): 162 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Makhseed, R. Raghupathy, F. Azizieh, R. Farhat, N. Hassan, and A. Bandar
Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions
Hum. Reprod., September 1, 2000; 15(9): 2011 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Gerli, C. Pitzalis, O. Bistoni, B. Falini, V. Costantini, A. Russano, and C. Lunardi
CD30+ T Cells in Rheumatoid Synovitis: Mechanisms of Recruitment and Functional Role
J. Immunol., April 15, 2000; 164(8): 4399 - 4407.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Annunziato, G. Galli, F. Nappi, L. Cosmi, R. Manetti, E. Maggi, B. Ensoli, and S. Romagnani
Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha , and MIP-1beta
Blood, February 15, 2000; 95(4): 1167 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
H. Akiba, Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura
Critical Contribution of OX40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis
J. Exp. Med., January 17, 2000; 191(2): 375 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Prechtl, M. Roellinghoff, R. Scheper, S. P. C. Cole, R. G. Deeley, and M. Lohoff
The Multidrug Resistance Protein 1: A Functionally Important Activation Marker for Murine Th1 Cells
J. Immunol., January 15, 2000; 164(2): 754 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M.-P. PICCINNI, E. MAGGI, and S. ROMAGNANI
Environmental Factors Favoring the Allergen-specific Th2 Response in Allergic Subjects
Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 844 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Gerli, O. Bistoni, C. Lunardi, R. Giacomelli, C. Tomassini, P. Biagini, and C. Pitzalis
Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy
Rheumatology, December 1, 1999; 38(12): 1282 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Mori, C. Manuelli, N. Pimpinelli, C. Mavilia, E. Maggi, M. Santucci, B. Bianchi, P. Cappugi, B. Giannotti, and M.E. Kadin
CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+ T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression
Blood, November 1, 1999; 94(9): 3077 - 3083.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M.-S. Lin, M. A. Gharia, S. J. Swartz, L. A. Diaz, and G. J. Giudice
Identification and Characterization of Epitopes Recognized by T Lymphocytes and Autoantibodies from Patients with Herpes Gestationis
J. Immunol., April 15, 1999; 162(8): 4991 - 4997.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
E. Yamaguchi, J. de Vries, and H. Yssel
Differentiation of human single-positive fetal thymocytes in vitro into IL-4- and/or IFN-{gamma}-producing CD4+ and CD8+ T cells
Int. Immunol., April 1, 1999; 11(4): 593 - 603.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Rogge, A. Papi, D. H. Presky, M. Biffi, L. J. Minetti, D. Miotto, C. Agostini, G. Semenzato, L. M. Fabbri, and F. Sinigaglia
Antibodies to the IL-12 Receptor {beta}2 Chain Mark Human Th1 But Not Th2 Cells In Vitro and In Vivo
J. Immunol., April 1, 1999; 162(7): 3926 - 3932.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
W. A. Hanekom, G. D. Hussey, E. J. Hughes, S. Potgieter, R. Yogev, and I. J. Check
Plasma-Soluble CD30 in Childhood Tuberculosis: Effects of Disease Severity, Nutritional Status, and Vitamin A Therapy
Clin. Vaccine Immunol., March 1, 1999; 6(2): 204 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Jeannin, N. Herbault, Y. Delneste, G. Magistrelli, S. Lecoanet-Henchoz, G. Caron, J.-P. Aubry, and J.-Y. Bonnefoy
Human Effector Memory T Cells Express CD86: A Functional Role in Naive T Cell Priming
J. Immunol., February 15, 1999; 162(4): 2044 - 2048.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nagata, K. Tanaka, K. Ogawa, K. Kemmotsu, T. Imai, O. Yoshie, H. Abe, K. Tada, M. Nakamura, K. Sugamura, et al.
Selective Expression of a Novel Surface Molecule by Human Th2 Cells In Vivo
J. Immunol., February 1, 1999; 162(3): 1278 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. Xu, W. L. Chan, B. P. Leung, D. Hunter, K. Schulz, R. W. Carter, I. B. McInnes, J. H. Robinson, and F. Y. Liew
Selective Expression and Functions of Interleukin 18 Receptor on T Helper (Th) Type 1 but not Th2 Cells
J. Exp. Med., October 19, 1998; 188(8): 1485 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
D. Elewaut, F. De Keyser, N. De Wever, D. Baeten, N. Van Damme, G. Verbruggen, C. Cuvelier, and E. M Veys
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers
Ann Rheum Dis, August 1, 1998; 57(8): 480 - 486.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
E. Scala, M. Carbonari, P. Del Porto, M. Cibati, T. Tedesco, A. M. Mazzone, R. Paganelli, and M. Fiorilli
Lymphocyte Activation Gene-3 (LAG-3) Expression and IFN-{gamma} Production Are Variably Coregulated in Different Human T Lymphocyte Subpopulations
J. Immunol., July 1, 1998; 161(1): 489 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Lohning, A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J.-C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
PNAS, June 9, 1998; 95(12): 6930 - 6935.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. Xu, W. L. Chan, B. P. Leung, F.-p. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Liew
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
J. Exp. Med., March 2, 1998; 187(5): 787 - 794.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Gilfillan, P. J. Noel, E. R. Podack, S. L. Reiner, and C. B. Thompson
Expression of the Costimulatory Receptor CD30 Is Regulated by Both CD28 and Cytokines
J. Immunol., March 1, 1998; 160(5): 2180 - 2187.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Coppola, A. Veronesi, S. Indraccolo, F. Calderazzo, M. Mion, S. Minuzzo, G. Esposito, D. Mauro, B. Silvestri, P. Gallo, et al.
Lymphoproliferative Disease in Human Peripheral Blood Mononuclear Cell-Injected SCID Mice. IV. Differential Activation of Human Th1 and Th2 Lymphocytes and Influence of the Atopic Status on Lymphoma Development
J. Immunol., March 1, 1998; 160(5): 2514 - 2522.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Leonard, V. Tormey, C. Burke, and L. W. Poulter
Allergen-induced Cytokine Production in Atopic Disease and Its Relationship to Disease Severity
Am. J. Respir. Cell Mol. Biol., September 1, 1997; 17(3): 368 - 375.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. M. Essayan, A. Kagey-Sobotka, L. M. Lichtenstein, and S.-K. Huang
Differential Regulation of Human Antigen-Specific Th1 and Th2 Lymphocyte Responses by Isozyme Selective Cyclic Nucleotide Phosphodiesterase Inhibitors
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 505 - 512.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Okumura, Y. Hidaka, S. Kuroda, K. Takeoka, H. Tada, and N. Amino
Increased Serum Concentration of Soluble CD30 in Patients with Graves' Disease and Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1757 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Gattei, M. Degan, A. Gloghini, A. De Iuliis, S. Improta, F. M. Rossi, D. Aldinucci, V. Perin, D. Serraino, R. Babare, et al.
CD30 Ligand Is Frequently Expressed in Human Hematopoietic Malignancies of Myeloid and Lymphoid Origin
Blood, March 15, 1997; 89(6): 2048 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. N. Tsitsikov, D. A. Wright, and R. S. Geha
CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2
PNAS, February 18, 1997; 94(4): 1390 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. W. Gedrich, M. C. Gilfillan, C. S. Duckett, J. L. Van Dongen, and C. B. Thompson
CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing Proteins
J. Biol. Chem., May 31, 1996; 271(22): 12852 - 12858.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Romagnani and E. Maggi
Response
Science, January 27, 1995; 267(5197): 539 - 539.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The Federation of American Societies for Experimental Biology.